NEXT-GEN THERMOGRAPHY
WORRY FREE DIAGNOSIS: NON-TOXIC & NON-INVASIVE
FULL TEST + IN PERSON EXAM FOR $150 ($499 VALUE)
LIMITED TIME ONLY
AlfaSight Thermography directs you to the ROOT CAUSE and opens up your vision to dental, whole-body, and breast dynamics objectively. FDA cleared.
The AlfaSight 9000 system measures skin temperature at more than 100 points on the body using a non-contact infrared sensor. The test involves taking two sets of readings (before and after a brief cooling period) to assess the body’s regulatory response.
The AlfaSight 9000 is an adjunct diagnostic tool. It doesn’t diagnose on its own but flags patterns that warrant further conventional testing. Its uses fall into two tiers:
FDA-Cleared Indications (510(k))
The device is officially cleared for the adjunct diagnosis of:
- Abnormalities of the female breast
- Peripheral vascular disease
- Musculoskeletal disorders
- Extracranial cerebral and facial vascular disease
- Abnormalities of the thyroid gland
- Various neoplastic (cancerous) and inflammatory conditions
Beyond the FDA list, clinics using the system report it recognizes patterns related to:
- Diabetes and pre-diabetes (pancreas)
- Liver disease and dysfunction
- Endocrine disorders (pituitary, thyroid, ovary)
- Cardiac function (efficiency, electrophysiology)
- Prostate dysfunction
- Pulmonary function
- Dental/focal infections
- Lyme disease and related infections
- Heavy metal toxicity
- Kidney dysfunction
- Gastrointestinal dysbiosis
- Autonomic nervous system abnormalities
- Lymphatic blockage/stasis
- Viral and bacterial disease monitoring
The system can detect physiological changes up to ~5 years before a disease becomes identifiable through conventional methods (e.g., spotting breast abnormalities years before a mammogram would show a tumor) based on a pattern-recognition database of over 100,000 patient assessments.
The AlfaSight’s intended use is as a screening layer— it flags suspicious patterns and helps a physician decide whether and where to order an MRI, CT, or lab work.It is not a replacement for mammography or any other imaging method and is not intended to serve as a sole diagnostic screening procedure.
Thermometry shows function, the imaging shows structure.
The scientific evidence for the AlfaSight 9000 is limited and largely non-independent. Here’s the breakdown:
The AlfaSight 9000 is a non-invasive, FDA-cleared adjunct diagnostic device infrared technology to assess the body’s autonomic nervous system and physiological regulation. By measuring skin temperature at approximately 119–120 body points before and after a mild cool-air stress, it identifies functional patterns and dysfunctions in organs and tissues that may not yet be visible through conventional imaging.
Key capabilities include:
- Early Detection: It aims to identify physiological stress and disease patterns (such as breast abnormalities, thyroid issues, or cardiac dysfunction) potentially years before pathological changes occur.
- Systemic Assessment: It evaluates organ function, inflammatory conditions, and neoplastic tendencies by analyzing how the body responds to thermal stress via the sympathetic nervous system.
- Clinical Utility: As an adjunct tool, it provides clinicians with data to prioritize further testing and personalized treatment plans, though it is not intended to serve as a sole diagnostic method or replace standard imaging like mammograms
To learn more about Alfa Sight, watch the video below. If you’d interested in thermography, or any of our other services, chat with us!
